AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Clinical trial NCT04432857 · UNKNOWN

Trial details

NCT number: NCT04432857
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Triple-negative Breast Cancer NSCLC, Squamous or Non-Squamous Urothelial Carcinoma of the Bladder Microsatellite Stable (MSS) Colorectal Cancer (CRC)Cervical Cancer

Start date: 2020-08-20
Primary completion: 2024-05-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.